Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing.

Healey JS, Dorian P, Mitchell LB, Talajic M, Philippon F, Simpson C, Yee R, Morillo CA, Lamy A, Basta M, Birnie DH, Wang X, Nair GM, Crystal E, Kerr CR, Connolly SJ; CREDIT Investigators.

J Cardiovasc Electrophysiol. 2010 Feb;21(2):177-82. doi: 10.1111/j.1540-8167.2009.01616.x. Epub 2009 Oct 5.

PMID:
19804544
2.

Defibrillation testing: the need for a definitive trial.

Duray GZ, Hohnloser SH.

J Cardiovasc Electrophysiol. 2010 Feb;21(2):183-5. doi: 10.1111/j.1540-8167.2009.01620.x. Epub 2009 Oct 5. No abstract available.

PMID:
19804540
3.

Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry.

Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS, Dorian P, Chen Z, Cameron D, Verma A, Connolly SJ, Gula LJ, Lockwood E, Nair G, Tu JV; Ontario ICD Database Investigators.

J Cardiovasc Electrophysiol. 2010 Dec;21(12):1344-8. doi: 10.1111/j.1540-8167.2010.01850.x.

PMID:
20662988
4.

Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey.

Brignole M, Raciti G, Bongiorni MG, De Martino G, Favale S, Gasparini M, Luise R, Occhetta E, Proclemer A.

Europace. 2007 Jul;9(7):540-3. Epub 2007 May 16.

PMID:
17507358
5.

Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.

Russo AM, Wang Y, Al-Khatib SM, Curtis JP, Lampert R.

Pacing Clin Electrophysiol. 2013 Dec;36(12):1522-31. doi: 10.1111/pace.12248. Epub 2013 Aug 26.

PMID:
23981009
6.

Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?

Calvi V, Dugo D, Capodanno D, Arancio R, Di Grazia A, Liotta C, Puzzangara E, Ragusa A, Arestia A, Tamburino C.

Am Heart J. 2010 Jan;159(1):98-102. doi: 10.1016/j.ahj.2009.10.031.

PMID:
20102873
7.

[Is DFT testing still mandatory?].

Neuzner J.

Herz. 2005 Nov;30(7):601-6. German.

PMID:
16333585
8.

Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.

Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D'Acri MG, Klersy C, Gasparini M; SAFE-ICD Study Investigators.

J Am Coll Cardiol. 2012 Sep 11;60(11):981-7. doi: 10.1016/j.jacc.2012.05.014. Epub 2012 Aug 1.

9.

A Comparison of ICD implantations in the United States versus Italy.

Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C, Proclemer A.

Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S143-6. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1427.

PMID:
17302692
10.

The dilemma of ICD implant testing.

Swerdlow CD, Russo AM, Degroot PJ.

Pacing Clin Electrophysiol. 2007 May;30(5):675-700. Review.

PMID:
17461879
11.

A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial.

Healey JS, Gula LJ, Birnie DH, Sterns L, Connolly SJ, Sapp J, Crystal E, Simpson C, Exner DV, Kus T, Philippon F, Wells G, Tang AS.

J Cardiovasc Electrophysiol. 2012 Dec;23(12):1313-6. doi: 10.1111/j.1540-8167.2012.02393.x. Epub 2012 Jul 12.

PMID:
22788915
12.

Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry.

Pedretti RF, Curnis A, Massa R, Morandi F, Tritto M, Manca L, Occhetta E, Molon G, De Ferrari GM, Sarzi Braga S, Raciti G, Klersy C, Salerno-Uriarte JA; ALPHA Study Group Investigators.

Europace. 2010 Aug;12(8):1105-11. doi: 10.1093/europace/euq106. Epub 2010 Apr 17.

PMID:
20400768
13.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

14.

Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study.

Calò L, Gargaro A, De Ruvo E, Palozzi G, Sciarra L, Rebecchi M, Guarracini F, Fagagnini A, Piroli E, Lioy E, Chirico A.

J Interv Card Electrophysiol. 2013 Jun;37(1):69-78. doi: 10.1007/s10840-013-9783-9. Epub 2013 Mar 21.

PMID:
23515883
15.

Incidence and clinical predictors of low defibrillation safety margin at time of implantable defibrillator implantation.

Cheng Z, Turakhia M, Lo R, Gupta A, Zei PC, Hsia HH, Al-Ahmad A, Wang PJ.

J Interv Card Electrophysiol. 2012 Jun;34(1):93-100. doi: 10.1007/s10840-011-9648-z. Epub 2012 Mar 6.

PMID:
22391960
16.

Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.

Bianchi S, Ricci RP, Biscione F, Sgreccia F, Di Belardino N, Rossi P, Giuli S, Grammatico A, De Santo T, Santi E, Merico M, Piccirillo G, Azzolini P, Santini M, Puglisi A.

Pacing Clin Electrophysiol. 2009 May;32(5):573-8. doi: 10.1111/j.1540-8159.2009.02329.x.

PMID:
19422577
17.

Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.

Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM.

Pacing Clin Electrophysiol. 2006 Dec;29 Suppl 2:S20-8.

PMID:
17169129
18.

High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems.

Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR; INTRINSIC RV Study Investigators.

Europace. 2008 Mar;10(3):347-50. doi: 10.1093/europace/eun027.

PMID:
18308755
19.

Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.

Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW.

Europace. 2009 Mar;11(3):297-302. doi: 10.1093/europace/eun322. Epub 2008 Dec 2.

PMID:
19054788
20.

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.

Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.

Supplemental Content

Support Center